The Multistakeholder Healthcare Environment – The Evolving Role of Regulators
In this article, we discuss our observations on today’s healthcare landscape and regulation of clinical research; how it continues to evolve the role of regulators in a multistakeholder environment.
CATEGORIES
BREXIT: What has Changed in the United Kingdom Clinical Trial Regulatory Landscape?
September 17, 2021
After years in the making, Brexit has occurred, and the...
The Multistakeholder Healthcare Environment – The Evolving Role of Regulators
July 15, 2021
In this article, we discuss our observations on today’s healthcare...
Phase 1/2 Combination Studies: Best Practices When Moving From Escalation to Expansion
May 17, 2021
In this article, we discuss best practices for combination Phase...
Precision for Medicine: Powered by Our People
April 05, 2021
Precision for Medicine as a global CRO, invests in our...
Next Generation Immune Monitoring in Immuno-oncology Trials
March 17, 2021
A critical component of I-O studies, immune monitoring is essential...
Taking a Holistic Approach to Sample Management and Sample Processing for Your Clinical Trial
February 04, 2021
Patient samples have always been critical assets for clinical trial...
